Document:

Exhibit
10.43

WAIVER

THIS WAIVER (“Waiver”)
is made and entered into as of this 14th day of June, 2007, by and among
Averion International Corp., a Delaware corporation (formerly IT&E
International Group and referred to herein as the “Company”), and Gene Resnick
(the “Holder”). Capitalized terms used herein and undefined shall have the
meanings set forth in that certain Registration Rights Agreement (defined in
the Recitals below).

RECITALS:

WHEREAS, reference
is made to that certain Registration Rights Agreement dated as of November 9,
2005 (the “Registration Rights Agreement”), by and among the Company and the
Holder;

WHEREAS, Section
2.3 of the Registration Rights Agreement affords the undersigned Holder the
opportunity to have Registrable Securities of the Holder included in a
registration statement filed by the Company (the “Piggyback Rights”);

WHEREAS, the
Company has informed the Holder that it intends to file a registration
statement on or before June 15, 2007 (the “Registration Statement”);

WHEREAS, Sections
2.11 and 3.5 of the Registration Rights Agreement permit any provision of the
Registration Rights Agreement to be waived upon the written consent of the
Holder or Holders representing at least a majority of the Registrable
Securities;

WHEREAS, the
undersigned Holder desires to waive such Holder’s Piggyback Rights with respect
to the Registration Statement;

NOW, THEREFORE, in
consideration of the foregoing recitals and the mutual agreements herein
contained and for other good and valuable consideration, the parties hereto
agree as follows:

1. WAIVER.

(a) The Holder
agrees to waive its Piggyback Rights contained in Section 2.3 of the
Registration Rights Agreement with respect to the Registration Statement (as
defined above);

(b) Except as
expressly set forth herein, this Waiver shall not be deemed to be a waiver,
amendment or modification of any provisions of the Registration Rights
Agreement or of any right, power or remedy of the Holder, or constitute a
waiver of any provision of the Registration Rights Agreement (except to the
extent herein set forth), or any other document, instrument and/or agreement
executed or delivered in connection therewith, in each case whether arising
before or after the date hereof or as a result of

performance hereunder or
thereunder. Except as set forth herein, the Holder reserves all rights,
remedies, powers, or privileges.

2.
CONFLICTS.  Except
as expressly set forth in this Waiver, the terms and provisions of the
Registration Rights Agreement shall continue unmodified and in full force and
effect. In the event of any conflict between this Waiver and the Registration
Rights Agreement, this Waiver shall control.

3.
GOVERNING LAW. 
This Waiver shall be governed and construed under the laws of the State
of Delaware, and shall be binding on and shall inure to the benefit of the
parties and their respective successors and permitted assigns.

4.
COUNTERPARTS. This Waiver may be executed in any number
of counterparts, each of which shall be an original, but all of which together shall
constitute one instrument.

IN WITNESS
WHEREOF, the parties hereto have executed this Waiver as of the date first set
forth above.

	
  COMPANY:

  
	
   

  
	
  Averion International Corp.

  
	
   

  
	
  By:

  	
  /s/ Christopher Codeanne

  	
   

  
	
  Name:

  	
  Christopher Codeanne

  
	
  Title:

  	
  Chief Financial Officer

  
	
   

  	
   

  
	
  HOLDER:

  
	
   

  
	
  Gene Resnick, M.D.

  
	
   

  
	
  By:

  	
  /s/ Gene Resnick

  	
   

  
	
  Name:

  	
  Gene Resnick, M.D.Exhibit
10.44

WAIVER

THIS WAIVER (“Waiver”)
is made and entered into as of this 14th day of June, 2007, by and among
Averion International Corp., a Delaware corporation (formerly IT&E
International Group and referred to herein as the “Company”), and the undersigned
Stockholders (each a “Holder” and collectively the “Holders”). Capitalized
terms used herein and undefined shall have the meanings set forth in that
certain Registration Rights Agreement (defined in the Recitals below).

RECITALS:

WHEREAS, reference
is made to that certain Registration Rights Agreement dated as of July 31, 2006
(the “Registration Rights Agreement”), by and among the Company and the
Holders;

WHEREAS, Section
2.3 of the Registration Rights Agreement affords the undersigned Holders the
opportunity to have Registrable Securities of such Holders included in a
registration statement filed by the Company (the “Piggyback Rights”);

WHEREAS, the
Company has informed the Holders that it intends to file a registration
statement on or before June 15, 2007 (the “Registration Statement”);

WHEREAS, Sections
2.11 and 3.5 of the Registration Rights Agreement permit any provision of the
Registration Rights Agreement to be waived upon the written consent of the
Holder or Holders representing at least a majority of the Registrable
Securities;

WHEREAS, the
undersigned Holders desire to waive such Holders’ Piggyback Rights with respect
to the Registration Statement;

NOW, THEREFORE, in
consideration of the foregoing recitals and the mutual agreements herein contained
and for other good and valuable consideration, the parties hereto agree as
follows:

1. WAIVER.

(a) The
undersigned Holders agree to waive their respective Piggyback Rights contained
in Section 2.3 of the Registration Rights Agreement with respect to the
Registration Statement (as defined above);

(b) Except as
expressly set forth herein, this Waiver shall not be deemed to be a waiver,
amendment or modification of any provisions of the Registration Rights
Agreement or of any right, power or remedy of any Holder, or constitute a
waiver of any provision of the Registration Rights Agreement (except to the
extent herein set forth), or any other document, instrument and/or agreement
executed or delivered in connection

therewith, in each case
whether arising before or after the date hereof or as a result of performance
hereunder or thereunder. Except as set forth herein, the Holders reserve all
rights, remedies, powers, or privileges.

2.
CONFLICTS.  Except
as expressly set forth in this Waiver, the terms and provisions of the
Registration Rights Agreement shall continue unmodified and in full force and
effect. In the event of any conflict between this Waiver and the Registration
Rights Agreement, this Waiver shall control.

3.
GOVERNING LAW. 
This Waiver shall be governed and construed under the laws of the State
of Delaware, and shall be binding on and shall inure to the benefit of the
parties and their respective successors and permitted assigns.

4.
COUNTERPARTS. This Waiver may be executed in any number
of counterparts, each of which shall be an original, but all of which together
shall constitute one instrument.

[Remainder
of page intentionally left blank]

IN WITNESS
WHEREOF, the parties hereto have executed this Waiver as of the date first set
forth above.

	
  COMPANY:

  
	
   

  
	
  Averion International Corp.

  
	
   

  
	
  By:

  	
  /s/ Christopher Codeanne

  	
   

  
	
  Name:

  	
  Christopher Codeanne

  
	
  Title:

  	
  Chief Financial Officer

  
	
   

  
	
  HOLDERS:

  
	
   

  
	
  Philip T. Lavin

  
	
   

  
	
  By:

  	
  /s/ Philip T. Lavin

  	
   

  
	
  Name:

  	
  Philip T. Lavin

  
	
   

  
	
  David A. Schoenfeld

  
	
   

  
	
  By:

  	
   

  	
   

  
	
  Name:

  	
  David A. Schoenfeld

  
	
   

  	
   

  
	
  Ellen Schoenfeld Beeks

  
	
   

  
	
  By:

  	
   

  	
   

  
	
  Name:

  	
  Ellen Schoenfeld Beeks

  
	
   

  
	
  Andrew Lavin

  
	
   

  
	
  By:

  	
   

  	
   

  
	
  Name:

  	
  Andrew Lavin

  
	
   

  	
   

  
	
  Abby G. Lavin

  
	
   

  	
   

  
	
  By:

  	
  /s/ Abby G. Lavin

  	
   

  
	
  Name:

  	
  Abby G. LavinExhibit 10.7

TELEPHONE
AND DATA SYSTEMS, INC. (the “Company”)

Compensation Plan for
Non-Employee Directors (the “Plan”)

As Amended, Effective May 10,
2007

The purpose of the Plan is to provide appropriate
compensation to non-employee directors for their service to the Company and to
ensure that qualified persons serve as non-employee members of the Board of
Directors.

The Plan was approved pursuant to the authority
granted in Section 2.22 of Article II of the Company’s By-Laws, which provides
that the Board of Directors shall have authority to establish reasonable
compensation of directors, including reimbursement of expenses incurred in
attending meetings of the Board of Directors.

Board Service

Each director of the Company who is not an employee of
the Company, TDS Telecommunications Corporation, United States Cellular
Corporation or any other subsidiary of the Company (“non-employee director”)
will receive:

1.               An
annual director’s retainer fee of $45,000 paid in cash.

2.               An
annual award of $45,000 paid in the form of the Company’s Special Common
Shares, which shall be distributed in March on or prior to March 15 of each
year, beginning March 15, 2008, for services performed during the 12 month
period that commences on March 1 of the immediately preceding calendar year and
ends on the last day of February of the calendar year of payment.  The number of shares shall be determined on
the basis of the closing price of the Company’s Special Common Shares, as
reported in the American Stock Exchange Composite Transaction section of the
Wall Street Journal for the last trading day in the month of February of each
year.

3.               A
director’s meeting fee of $1,750 for each meeting attended and reimbursement of
reasonable expenses incurred in connection with attendance at meetings of the
Board of Directors, paid in cash.

4.               The
Chairperson of the Board of Directors will receive an additional annual
retainer fee of $45,000, paid in cash.

Audit Committee Service

Each non-employee director who serves on the Audit
Committee, other than the Chairperson, will receive an annual committee
retainer fee of $11,000, a committee meeting fee of $1,750 for each meeting
attended and reimbursement of reasonable expenses incurred in connection with
attendance at meetings of the Audit Committee. 
The Audit Committee Chairperson will receive an annual retainer fee of
$22,000, a committee meeting fee of $1,750 for each meeting attended and
reimbursement of reasonable expenses incurred in connection with attendance at
such meeting.

Compensation Committee
Service

Each non-employee director of the Company who serves
on the Compensation Committee, other than the Chairperson, will receive an
annual committee retainer fee of $7,000, a committee meeting fee of $1,750 for
each meeting attended and reimbursement of reasonable expenses incurred in
connection with attendance at each meeting of the committee.  The Compensation Committee Chairperson will
receive an annual retainer fee of $14,000, a committee meeting fee of $1,750
for each meeting attended and reimbursement of reasonable expenses incurred in
connection with attendance at such meeting.

Corporate Governance
Committee Service

Each non-employee director of the Company who serves
on the Corporate Governance Committee, other than the Chairperson, will receive
an annual committee retainer fee of $5,000, a committee meeting fee of $1,750
for each meeting attended and reimbursement of reasonable expenses incurred in
connection with attendance at meetings of the Corporate Governance Committee.  The Corporate Governance Committee
Chairperson will receive an annual retainer fee of $10,000, a committee meeting
fee of $1,750 for each meeting attended and reimbursement of reasonable
expenses incurred in connection with attendance at such meeting.

Under the Plan, annual retainers will be paid in cash
on a quarterly basis, as of the last day of each calendar quarter, and will
compensate the non-employee director for services performed during such
calendar quarter.

Fees for meetings of the board and all committee meetings
will be paid in cash on a quarterly basis as of the last day of each calendar
quarter, and will compensate the non-employee director for meetings attended
during such calendar quarter.

Non-employee directors shall timely submit for
reimbursement their reasonable expenses incurred in connection with meeting
attendance, and the Company shall reimburse such expenses within two weeks
after submission.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]